Recent studies have demonstrated in obese models of NASH, a pathogenic subset of hepatic CD8+ T cells that are elevated and regulate hepatic inflammation and fibrosis (3–8). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.